Quadriceps strength in patients with chronic obstructive pulmonary disease

Swati Shah, Bhushan Darekar, Sundeep Salvi, Arun Kowale, Swati Shah, Bhushan Darekar, Sundeep Salvi, Arun Kowale

Abstract

Background: Skeletal muscle dysfunction is well known in chronic obstructive pulmonary disease (COPD). The muscle strength is altered in various muscles variedly. Lower-limb muscle strength is very important for walking distance. Reduced lower-limb strength can affect the physical quality of life.

Objectives: The aim of the study was to assess and compare the quadriceps strength in COPD patients and age-matched healthy controls and to study the correlation between lung function parameters and the quadriceps strength in patients with COPD.

Methodology: Thirty nonsmoker male patients; thirty nonsmoker female patients with COPD; and sixty age-, BMI-, and gender-matched healthy controls were studied. Quadriceps muscle strength was measured using a quadriceps dynamometer. Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEF 25-75, and peak expiratory flow rate were measured using Helios 702 Spirometer. The quadriceps muscle strength between the two groups was compared using the unpaired Student's t-test. Correlations between FVC and FEV1with muscle strength were analyzed using the Pearson's coefficient.

Results: The mean unilateral and bilateral quadriceps strength in both male and female COPD patients was significantly lesser than the healthy controls (P < 0.05). There was a significant positive correlation between muscle strength and FVC and muscle strength and FEV1in patients with COPD.

Conclusion: The study shows that there is quadriceps weakness in COPD patients, and pulmonary functions have a direct impact on skeletal muscle strength. Identifying those patients who have reduced strength will allow early interventions targeted at improving the quality of life of the patient.

Keywords: Chronic obstructive pulmonary disease; forced vital capacity; muscle strength; quadriceps.

Conflict of interest statement

None

References

    1. The Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018. [Last accessed on 2018 Jul 09]. Available from: .
    1. Barne M, Salvi S. Health and economic burden of chronic obstructive pulmonary disease. In: Jindal SK, editor. Textbook of Pulmonary and Critical Care Medicine. Vol. 1. New Delhi: Jaypee Brothers Medical Publishers; 2011. pp. 975–86.
    1. Casaburi R, Gosselink R, Decramer M, Dekhuijzen RP, Fournier M, Lewis MI, et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease – A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159:S1–40.
    1. van Eeden SF, Yeung A, Quinlam K, Hogg JC. Systemic response to ambient particulate matter: Relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:61–7.
    1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–64.
    1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–55.
    1. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43.
    1. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.
    1. Man WD, Soliman MG, Nikoletou D, Harris ML, Rafferty GF, Mustfa N, et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax. 2003;58:665–9.
    1. Allaire J, Maltais F, Doyon JF, Noël M, LeBlanc P, Carrier G, et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax. 2004;59:673–8.
    1. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62:115–20.
    1. Kharbanda S, Ramakrishna A, Krishnan S. Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity. Int J Chron Obstruct Pulmon Dis. 2015;10:1727–35.
    1. Gosker HR, Schols AM. Fatigued muscles in COPD but no finishing line in sight. Eur Respir J. 2008;31:693–4.
    1. Maltais F, LeBlanc P, Whittom F, Simard C, Marquis K, Bélanger M, et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax. 2000;55:848–53.
    1. Mathur S, Brooks D, Carvalho CR. Structural alterations of skeletal muscle in copd. Front Physiol. 2014;5:104.
    1. Kao CC, Hsu JW, Bandi V, Hanania NA, Kheradmand F, Jahoor F. Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J Appl Physiol ( 1985;2012(112):42–7.
    1. Raguso CA, Luthy C. Nutritional status in chronic obstructive pulmonary disease: Role of hypoxia. Nutrition. 2011;27:138–43.
    1. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012;40:1115–22.
    1. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36:81–8.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する